United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops and commercializes medications for chronic lung diseases and ...

We expect an in-line return from the stock in the next few months. United Therapeutics is part of the Zacks Medical - Drugs industry. Over the past month, Zoetis (ZTS), a stock from the same ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop.

United Therapeutics Corporation (NASDAQ ... and collaborates with other companies on various drug development projects. It is also one of the 10 best healthcare stocks for long-term investment.

After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...